Global Nicotinamide Mononucleotide Market Witnesses Fast Growth with CAGR of 9.95% - QYResearch Report
QYResearch has published a new report on the global Nicotinamide Mononucleotide market revealing that, over the next six years the Nicotinamide Mononucleotide (NMN) market will register a 9.95% CAGR in terms of revenue, the global market size will reach US$ 370.25 million by 2026, from US$ 107.74 million in 2019.
Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. NMN is made from B vitamins in the body, and is a molecule naturally occurring in all life forms.
Nicotinamide adenine dinucleotide (NAD) is a vital metabolic redox co-enzyme found in eukaryotic cells and is necessary for over 500 enzymatic reactions. It plays a crucial role in various biological processes, including metabolism, aging, cell death, DNA repair, and gene expression. Thus, NAD+ is critical for human health and longevity.
Nicotinamide mononucleotide (NMN) is one of the intermediates in NAD+ biosynthesis and is a bioactive nucleotide formed by the reaction between a phosphate group and a nucleoside containing ribose and nicotinamide.
Global Nicotinamide Mononucleotide Market- Key Players
Currently, there are only several companies selling this product, such as GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway. The industry is highly concentrated. In 2019, GeneHarbor took about 28.14% of global NMN revenue while Shinkowa Pharmaceutical owned 27.98% share. The top 5 suppliers dominate the global 83% sales share.
Global Nicotinamide Mononucleotide Market: Application Analysis
Nicotinamide Mononucleotide can be used in the production of Health Care Products and Cosmetics. The importance of NAD+ in human health has been gaining prominence in recent years, with companies developing supplements which are said to increase the levels of NAD+ in the body. These supplements mainly come in two forms, either NMN or nicotinamide riboside (NR).
One of the most well-known companies is Chromadex with its flagship NR supplement Tru Niagen. The product, being available in both Western and Asian markets, is said to be the only commercially available form of NR.
The greater demand of health products and the desire for anti-ageing will stimulate the demand of Nicotinamide Mononucleotide continually.
Read More Information: https://www.qyresearch.com/index/detail/2628115/global-nicotinamide-mononucleotide-nmn-market
QYResearch provides Market Research Reports for clients all over the world. As of now, QYResearch data as following:
62000 + Clients(cover 100% the world strong 500 companies and most industries’ leading players such as TOP5 players)
7800 + Experts(most of them with more than 15 years’ experience in their industry and professional knowledge both in market and technology)
300 + Data Base(40% government related data base, 30% third part data base, 10% international agencies data base, 30% technology and market data base)
2 Million + Reports(cover almost all industries and most detailed products such as product model level research reports, where you can find all what you need in one shop)
1000 + Custom Research Projects(most clients need custom research service and QYResearch keeps offering good and depth service for them)
30 + Roles Data Interview Checking System(only QYResearch uses such interview system with more than 30 roles in order to confirm the data reliability)
13 + Years focus market research and continues to support the client success.
Rahul Singh - Digital Marketing Director
Contact: +91 7028 920 828 +81-903-800-9273 +86-108-294-5717
Sales Contact US:
USA Registered Office: QY Research, INC.
17890 Castleton, Suite 369,
City of industry, CA - 91748
Emails – email@example.com
Web – www.qyresearch.com